These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2903395)

  • 41. The Rationale for Growth Hormone Therapy in Children with Short Stature.
    Deodati A; Cianfarani S
    J Clin Res Pediatr Endocrinol; 2017 Dec; 9(Suppl 2):23-32. PubMed ID: 29280742
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Establishment and validation of predictive model of short term responses to recombinant human growth hormone treatment in prepubertal short stature children with various growth hormone secretary statuses].
    Su Z; Li YH; Ma HM; Chen HS; DU ML; Gu YF
    Zhonghua Er Ke Za Zhi; 2008 Oct; 46(10):757-62. PubMed ID: 19099881
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of short stature in children and adolescents.
    Wright JC
    Indiana Med; 1984 Jul; 77(7):515-9. PubMed ID: 6747266
    [No Abstract]   [Full Text] [Related]  

  • 44. Short Stature: Is It a Psychosocial Problem and Does Changing Height Matter?
    Sandberg DE; Gardner M
    Pediatr Clin North Am; 2015 Aug; 62(4):963-82. PubMed ID: 26210627
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The management of small stature in children].
    Cabrol S; Lasfargues G
    Ann Pediatr (Paris); 1989 Nov; 36(9):628-31. PubMed ID: 2574020
    [No Abstract]   [Full Text] [Related]  

  • 46. Use of growth hormone in the treatment of short stature: boon or abuse?
    Saenger P
    Pediatr Rev; 1991 Jun; 12(12):355-63. PubMed ID: 2062746
    [No Abstract]   [Full Text] [Related]  

  • 47. Three-year growth hormone treatment in short children with X-linked hypophosphatemic rickets: effects on linear growth and body disproportion.
    Živičnjak M; Schnabel D; Staude H; Even G; Marx M; Beetz R; Holder M; Billing H; Fischer DC; Rabl W; Schumacher M; Hiort O; Haffner D;
    J Clin Endocrinol Metab; 2011 Dec; 96(12):E2097-105. PubMed ID: 21994957
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Management of children with short stature.
    O'Shea D; Byrne M; Powell D
    Ir Med J; 1990 Mar; 83(1):25-7. PubMed ID: 2361835
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Anabolic steroids and growth].
    Bierich JR
    Minerva Med; 1971 Jun; 62(51):2572-9. PubMed ID: 5566870
    [No Abstract]   [Full Text] [Related]  

  • 50. [The standpoints on the therapy of tall stature in 1989].
    Hoepffner W; Canzler E; Göretzlehner G; Hesse V; Keller E; Mohnike K; Willgerodt H
    Padiatr Grenzgeb; 1990; 29(2):193-6. PubMed ID: 2352752
    [No Abstract]   [Full Text] [Related]  

  • 51. [Side-effects of the clonidine test in 20 children with short stature].
    Durá Trave T; Moya Benavent M; Buades Esplá A
    An Esp Pediatr; 1989 Jul; 31(1):39-42. PubMed ID: 2802406
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The treatment of tall stature in boys].
    Knorr D
    Padiatr Grenzgeb; 1990; 29(2):185-7. PubMed ID: 2352750
    [No Abstract]   [Full Text] [Related]  

  • 53. The short child: clinical assessment and treatment.
    Gregory JW
    Br J Hosp Med; 1994 Oct 5-18; 52(7):339-41. PubMed ID: 7858815
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Statement 4: therapy should be offered to children with idiopathic short stature (ISS) whose heights are < -2.25 standard deviation (SD) score.
    Rosenthal SM
    Pediatr Endocrinol Rev; 2008 Apr; 5 Suppl 3():847-52. PubMed ID: 18438328
    [No Abstract]   [Full Text] [Related]  

  • 55. Auxological criteria for treating children with idiopathic short stature.
    Loche S
    Horm Res Paediatr; 2011; 76 Suppl 3():16-18. PubMed ID: 21912151
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term results of growth hormone treatment in France in children of short stature: population, register based study.
    Coste J; Letrait M; Carel JC; Tresca JP; Chatelain P; Rochiccioli P; Chaussain JL; Job JC
    BMJ; 1997 Sep; 315(7110):708-13. PubMed ID: 9314755
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Growth hormone therapy and children with idiopathic short stature: a viable option?
    Willhaus J
    Pediatr Nurs; 1999; 25(6):662-5. PubMed ID: 12024388
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment perspectives in idiopathic short stature with a focus on IGF-I deficiency.
    Rosenthal S; Cohen P; Clayton P; Backeljauw P; Bang P; Ten S
    Pediatr Endocrinol Rev; 2007 May; 4 Suppl 2():252-71. PubMed ID: 17581497
    [No Abstract]   [Full Text] [Related]  

  • 59. Recombinant growth hormone for idiopathic short stature in children and adolescents.
    Bryant J; Cave C; Milne R
    Cochrane Database Syst Rev; 2003; (4):CD004440. PubMed ID: 14584015
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of zinc on growth in short children.
    Graham GG
    J Pediatr; 1994 Jan; 124(1):163-4. PubMed ID: 8110294
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.